How Hepatic Lipase Deficiency is Diagnosed

Diagnosing hepatic lipase deficiency is a process of “connecting the dots” between your blood work, your genetic code, and the physical ways your body handles fat. Because the symptoms can overlap with other more common conditions, doctors use a combination of specialized tests to confirm the diagnosis and rule out “look-alike” disorders.

The Biological “Trimmer”

As discussed previously, your liver produces an enzyme called hepatic lipase ^[1]. Within the body, this enzyme acts like a precision trimmer for fat particles. It specifically breaks down triglycerides and phospholipids found on the surface of lipoproteins ^[2][1]. By removing these fats, it helps “remodel” larger particles into the specific sizes of LDL and HDL your body needs for health ^[1]. When the LIPC gene—which contains the blueprints for this enzyme—has certain variations, this trimming process slows down or stops, leaving your blood with fat particles that are incorrectly shaped or sized ^[3].

Reading the Lipid Profile

There is no “perfect” lipid pattern that everyone with this condition follows, but researchers have identified a common signature. In many people with confirmed hepatic lipase deficiency, blood tests show:

• Moderate Hypertriglyceridemia: Triglycerides are typically elevated but often not to the extreme levels seen in some other genetic disorders ^[4][3].
• Modest LDL and HDL Increases: Both your LDL-C and HDL-C may be higher than average ^[4].
• Unique HDL Particles: While your total HDL number might look high, the particles themselves are often unusual—some are much larger and others are much smaller than normal ^[4][5].

A Warning About Calculated LDL-C: When triglycerides are substantially elevated, standard panels that calculate LDL-C can be unreliable. Your clinician may instead use a direct LDL-C measurement, non-HDL-C, or apoB to get a dependable value. Because these findings can vary significantly, doctors rarely rely on a standard lipid panel alone to make the diagnosis ^[6].

Functional and Genetic Testing

To evaluate the deficiency, your care team may look at two types of advanced testing:

1. Post-Heparin Lipase Activity Testing
This specialized test measures how well your enzymes actually work. You are given a small dose of heparin (a blood thinner), which “kicks” the enzymes off the walls of your blood vessels and into your bloodstream so they can be measured.

• What it finds: It allows the lab to separately measure hepatic lipase and lipoprotein lipase (LPL) activity ^[7].
• Limitations: This test is not routinely available or uniformly standardized, and is highly variable. Results can change between patients or even in the same patient on different days ^[8]. Therefore, it is a supportive test rather than an automatic diagnostic gold standard ^[3].

2. Molecular (Genetic) Testing
This is an important part of the diagnosis, but it must be interpreted alongside your lipid pattern and family history by a lipid specialist.

• Targeted Sequencing: This looks for specific “spelling errors” in the LIPC gene ^[3].
• Deletion/Duplication Analysis: Sometimes, a piece of the gene is missing entirely. Standard sequencing might miss this, so specialized “copy number” testing is often needed to find these larger gaps ^[3][6].
• Biallelic Variants: To have the full deficiency, you typically need two “pathogenic” (disease-causing) or “likely pathogenic” variants—one from each parent. A single variant or a Variant of Uncertain Significance (VUS) does not confirm the diagnosis ^[3]. If family testing is pursued, it is usually targeted to the known familial variant.

Ruling Out “Look-Alike” Conditions

Because high cholesterol and triglycerides are common, your doctor must perform a differential diagnosis to ensure something else isn’t causing the problem. The patterns below are suggestive, but a full evaluation is required:

Confirming the diagnosis through genetic testing is the best way to ensure you are treating the right condition and can help your family members understand their own potential risks ^[3].